Literature DB >> 29031941

The travel diaries of tetanus and botulinum neurotoxins.

Sunaina Surana1, Andrew P Tosolini1, Ione F G Meyer2, Alexander D Fellows1, Sergey S Novoselov1, Giampietro Schiavo3.   

Abstract

Tetanus (TeNT) and botulinum (BoNT) neurotoxins, the causative agents of tetanus and botulism, respectively, are the most potent toxic molecules known to mankind. This extreme potency is attributed to: i) their specificity for essential components of the neurotransmitter release machinery present at vertebrate synapses, and ii) their high-affinity targeting to motor neurons by binding to polysialogangliosides and protein receptors. Comprising the clostridial neurotoxin family, TeNT and BoNTs engage distinct surface receptors and intracellular sorting pathways in neurons. BoNTs bind to the intraluminal domain of specific synaptic vesicle proteins that are exposed to the extracellular milieu upon exocytosis, and are taken up by synaptic vesicle recycling. A sizeable proportion of BoNT molecules remain at the neuromuscular junction, where their protease moiety is released into the cytoplasm, blocking synaptic transmission and causing flaccid paralysis. In contrast, TeNT undergoes binding to specific components of the basal membrane at the neuromuscular junction, is endocytosed into motor neurons and sorted to axonal signalling endosomes. Following this, TeNT is transported to the soma of motor neurons located in the spinal cord or brainstem, and then transcytosed to inhibitory interneurons, where it blocks synaptic transmission. TeNT-induced impairment of inhibitory input leads to hyperactivity of motor neurons, causing spastic paralysis, which is the hallmark of tetanus. This review examines the molecular mechanisms leading to the entry, sorting and intracellular trafficking of TeNT and BoNTs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axonal retrograde transport; Botulinum neurotoxin; Clostridial neurotoxin; Endocytosis; Neuromuscular junction; Tetanus toxin

Mesh:

Substances:

Year:  2017        PMID: 29031941     DOI: 10.1016/j.toxicon.2017.10.008

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  19 in total

1.  The Structure and Classification of Botulinum Toxins.

Authors:  Min Dong; Pål Stenmark
Journal:  Handb Exp Pharmacol       Date:  2021

2.  In Vivo Imaging of Anterograde and Retrograde Axonal Transport in Rodent Peripheral Nerves.

Authors:  James N Sleigh; Andrew P Tosolini; Giampietro Schiavo
Journal:  Methods Mol Biol       Date:  2020

Review 3.  Strategies for Targeted Delivery to the Peripheral Nerve.

Authors:  Kelly A Langert; Eric M Brey
Journal:  Front Neurosci       Date:  2018-11-27       Impact factor: 4.677

Review 4.  Retromer in Synaptic Function and Pathology.

Authors:  Lennart Brodin; Oleg Shupliakov
Journal:  Front Synaptic Neurosci       Date:  2018-10-24

5.  Axonal Transport as an In Vivo Biomarker for Retinal Neuropathy.

Authors:  Lucia G Le Roux; Xudong Qiu; Megan C Jacobsen; Mark D Pagel; Seth T Gammon; David R Piwnica-Worms; Dawid Schellingerhout
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

Review 6.  Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Authors:  Marco Pirazzini; Cesare Montecucco; Ornella Rossetto
Journal:  Arch Toxicol       Date:  2022-03-25       Impact factor: 6.168

7.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

Review 8.  Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?

Authors:  Bernard Poulain; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-01-11       Impact factor: 4.546

9.  The population structure of Clostridium tetani deduced from its pan-genome.

Authors:  Diana Chapeton-Montes; Lucile Plourde; Christiane Bouchier; Laurence Ma; Laure Diancourt; Alexis Criscuolo; Michel Robert Popoff; Holger Brüggemann
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

10.  Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes.

Authors:  James N Sleigh; Andrew P Tosolini; David Gordon; Anny Devoy; Pietro Fratta; Elizabeth M C Fisher; Kevin Talbot; Giampietro Schiavo
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.